Skip to main content
. 2015 Dec 10;4(4):671–689. doi: 10.3390/microarrays4040671

Table 2.

New samples for cross-validation.

Disease PAXgene Source
Lung Cancer 12 Malaysia
Liver Cancer 8 Malaysia
Nasopharyngeal Cancer 20 Malaysia
Prostate Cancer 25 Malaysia
Breast Cancer 12 Malaysia
Cervical Cancer 9 Malaysia
Colorectal Cancer 10 Malaysia
Ulcerative Colitis 10 China
Crohn’s Disease 9 China
Osteoarthritis 8 Malaysia
Healthy Controls 34 China/Malaysia
Total 157 85% Malaysia/15% China